Shay Capital LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 39 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
Shay Capital LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$20,000
-20.0%
10,0000.0%0.00%
+33.3%
Q1 2022$25,000
-32.4%
10,0000.0%0.00%
-50.0%
Q4 2021$37,000
-7.5%
10,0000.0%0.01%
+20.0%
Q3 2021$40,00010,0000.01%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders